Overview
A social scientist by training, Dr. Amy Corneli has conducted qualitative and mixed-method research in multiple countries in sub-Saharan Africa, the Middle East, South and Southeast Asia, and in the U.S. She has a long trajectory of working with community partners on research with populations who are disenfranchised due to race, ethnicity, sexuality, and/or gender, and of engaging key contributors in research to inform clinical trials and practice, socio-behavioral interventions, questionnaire/scale development, and the translation of proven interventions into practice. Her current research portfolio focuses on three areas: 1) leading qualitative and implementation science research in HIV prevention and other infectious diseases (gonorrhea and COVID-19), 2) serving as a methodological investigative partner on qualitative and mixed-methods research with faculty in the School of Medicine, and 3) serving as the leader of the social science team and PI of qualitative studies for the Clinical Trials Transformation Initiative, a public-private initiative between Duke University and the U.S. Food and Drug Administration. In addition, she is the 1) founder and Director of QualCore, a group of PhD- and master-level social scientists who provide scientific direction and interviewing and analysis expertise in qualitative research to Duke investigators, 2) co-founder and Director of The BASE (Bioethics and Stakeholder Engagement) Lab, a group of faculty and staff that partners with clinical investigators at Duke to conduct research with key stakeholders to inform the planning, conduct, interpretation, and reporting of clinical research, and 3) Director of the Duke CFAR Social and Behavioral Sciences Core.
QualCore | https://populationhealth.duke.edu/research/qualcore
The BASE Lab | https://populationhealth.duke.edu/research/base-lab
Duke CFAR Social and Behavioral Sciences Core | https://cfar.duke.edu
Clinical Trials Transformation Initiative| https://www.ctti-clinicaltrials.org